Genomic analysis of the CALGB 40603 (Alliance) neoadjuvant trial in TNBC identifies immune features associated with pathological complete response and event-free survival
- Citation:
- Cancer Res vol 81 (4 Supplement) PD9-03
- Meeting Instance:
- SABCS 2020
- Year:
- 2020
- Type:
- Abstract
- Sub type:
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Pharmas:
- Genentech
- Grants:
- U10CA180821, U10CA180882, U24CA196171
- Corr. Author:
- Authors:
- Jonathan H. Shepherd Cheng Fan Aranzazu Fernandez-Martinez Joel S. Parker Katherine A. Hoadley Zhiyuan Hu Yan Li Matthew G. Soloway Patricia A. Spears Ann Partridge Terry Hyslop William M. Sikov Lisa A. Carey Charles M. Perou
- Networks:
- KAISER, LAPS-MA036, LAPS-NC007, RI005
- Study
- CALGB-40603
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: